MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000534003

Медицинская библиотека · Digestive diseases (Basel, Switzerland) · 2023

Immunomodulatory Role of Mesenchymal Stem Cells in Liver Transplantation: Status and Prospects.

Li Haitao, Yu Saihua, Chen Lihong, Liu Hongzhi, Shen Conglong

СтатьяОбзорПеревод в очереди

Аннотация

BACKGROUND

Liver transplantation (LT) is the only effective therapy for end-stage liver diseases, but some patients usually present with serious infection and immune rejection. Those with immune rejection require long-term administration of immunosuppressants, leading to serious adverse effects. Mesenchymal stem cells (MSCs) have various advantages in immune regulation and are promising drugs most likely to replace immunosuppressants.

SUMMARY: This study summarized the application of MSCs monotherapy, its combination with immunosuppressants, MSCs genetic modification, and MSCs derivative therapy (cell-free therapy) in LT. This may deepen the understanding of immunomodulatory role of MSCs and promote the application of MSCs in immune rejection treatment after LT.

KEY MESSAGES: MSCs could attenuate ischemia-reperfusion injury and immune rejection. There is no consensus on the effects of types and concentrations of immunosuppressants on MSCs. Although genetically modified MSCs have contributed to better outcomes to some extent, the best modification is still unclear. Besides, multiple clinical complications developed frequently after LT. Unfortunately, there are still few studies on the polygenic modification of MSCs for the simultaneous treatment of these complications. Therefore, more studies should be performed to investigate the potency of multi-gene modified MSCs in treating complications after LT. Additionally, MSC derivatives mainly include exosomes, extracellular vesicles, and conditioned medium. Despite therapeutic effects, these three therapies still have some limitations such as heterogeneity between generations and that they cannot be quantified accurately.

Для цитирования: Li Haitao, Yu Saihua, Chen Lihong, Liu Hongzhi, Shen Conglong. Immunomodulatory Role of Mesenchymal Stem Cells in Liver Transplantation: Status and Prospects.. Digestive diseases (Basel, Switzerland). 2023. DOI: 10.1159/000534003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.